MedPath

GODART Pilot and Feasibility

Not Applicable
Active, not recruiting
Conditions
Diabetes Mellitus, Type 2
Interventions
Behavioral: Weekly Automated Health Coaching
Behavioral: Weekly Human Health Coaching
Behavioral: Fixed Gamified Reward Level
Behavioral: Adapted Reward Level
Registration Number
NCT05344859
Lead Sponsor
University of Alabama at Birmingham
Brief Summary

The purpose of this study is to pilot and assess the feasibility of implementing an artificial intelligence-assisted individualized lifestyle modification intervention for glycemic control in rural populations, which can be delivered even with regular landline phone service. This study will provide us with the knowledge to plan a well-powered optimization trial in the future to develop an optimal (low-cost) intervention package that can be delivered in a sustainable manner to the rural portions of America.

Detailed Description

Evidence-based guidelines for type 2 diabetes mellitus (T2DM) management aimed at glycemic control (reduced hemoglobin A1c) include a combination of diet, physical activity (PA), glucose monitoring, and medication adherences. However, the majority of individuals with T2DM are unable to follow these guidelines due to a lack of consistent health behavior counseling offered in the primary care setting. This problem is amplified in remote rural communities within the U.S. In response, this project aims to create an optimized telehealth-based intervention - Gamified Optimized Diabetes management with Artificial Intelligence-powered Rural Telehealth (GODART). GODART is grounded in the social cognitive theory and will serve as an automated behavior-monitoring and telecoaching platform. At the core, GODART is an automated conversational-style behavior-monitoring system using natural language-understanding technologies. In this project, we propose to pilot and feasibility test the various components of GODART by leveraging a multiphase optimization strategy (MOST). MOST is an efficient and rigorous resource-management and continuous- improvement framework for developing optimized interventions. Our proposal focuses on the MOST preparatory phase and will use full factorial experimentation. We will pilot and assess the feasibility of and evaluate two different intervention components, with two levels in each of the groups, yielding four experimental conditions. These groups will test the effect of (i) a fixed vs. adaptive (gamified) rewards program and (ii) automated vs. human-delivered weekly health coaching. We will end the project with exit interviews conducted with a subset of participants. Study findings will help us learn the feasibility of delivering such an intervention and its preliminary effectiveness in reducing HbA1c, leading to adequately powered confirmatory effectiveness studies.

Participants will be enrolled in the study in 2 phases:

Phase 1-The Feasibility Phase: Up to 16 participants will be enrolled in this phase of the study. Participants will be in the study for a duration of 14 days. This phase of the study is conducted to access the feasibility, usability, and accessibility of the GODART platform, before the actual intervention phase.

Phase 2- Intervention Phase: 88 participants will be enrolled in this phase of the study for a duration of 6 months.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
108
Inclusion Criteria
  1. a diagnosis of T2DM
  2. HbA1C ≥7% to ≤ 10.5% for phase 1- 14 days and phase 2 of the study- 6 months.
  3. ≥18 years of age
  4. the ability to converse in and read English.
Exclusion Criteria
  1. Present or soon-planned pregnancy
  2. Current enrollment in any structured lifestyle intervention study for diabetes or weight management.
  3. Patients currently on insulin treatment
  4. Major cardiac event in the past 6 months
  5. Renal failure in the past 6 months
  6. Listening and Speaking Impairment

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Arm 3Weekly Automated Health CoachingFixed Reward + Weekly automated coaching
Arm 4Fixed Gamified Reward LevelFixed Reward + Weekly human coaching
Arm 2Weekly Human Health CoachingAdaptive Rewards + Weekly human coaching
Arm 4Weekly Human Health CoachingFixed Reward + Weekly human coaching
Arm 1Weekly Automated Health CoachingAdaptive Rewards + Weekly automated coaching
Arm 1Adapted Reward LevelAdaptive Rewards + Weekly automated coaching
Arm 3Fixed Gamified Reward LevelFixed Reward + Weekly automated coaching
Arm 2Adapted Reward LevelAdaptive Rewards + Weekly human coaching
Primary Outcome Measures
NameTimeMethod
Change in Hemoglobin A1C level between screening and 6 months6 months

The inclusion criteria for a participant enrolling in the study is HbA1c ≥ 7% to ≤10.5% (for phase 1) and HbA1c ≥ 7% to ≤10.5% (phase 2). The primary outcome of the study is to track change in the HbA1C between baseline and 6 months (primary endpoint of the study). The HbA1C will be tested at baseline and 6 months. The measure of HbA1C at the end of 6 months (end of the intervention period) will be considered as the primary outcome measure to study the effectiveness of the interventions.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Family and Community Medicine, University of Alabama at Birmingham

🇺🇸

Birmingham, Alabama, United States

© Copyright 2025. All Rights Reserved by MedPath